Study estimates radiation dose, cancer risk from coronary artery calcium screening

July 13, 2009

CHICAGO - A study based on computer modeling of radiation risk suggests that widespread screening for the buildup of calcium in the arteries using computed tomography scans would lead to an estimated 42 additional radiation-induced cancer cases per 100,000 men and 62 cases per 100,000 women, according to a report in the July 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Coronary artery calcification is associated with coronary artery disease. "Computed tomography (CT) has been proposed as a tool for routine screening for coronary artery calcification in asymptomatic individuals as part of a comprehensive risk assessment," the authors write as background information in the article. Evidence suggests that this type of screening may detect the presence of calcium in the arteries of individuals who would be at low risk when assessed by traditional risk factors. "However, the potential risks of screening, including the risk of radiation-induced cancer, have to be considered along with the potential benefits."

Kwang Pyo Kim, Ph.D., then of the National Cancer Institute, Bethesda, Md., and now of Kyung Hee University, Gyeonggi-do, Republic of Korea, and colleagues estimated the radiation doses delivered to adult patients undergoing CT screening for coronary artery calcification from a range of available protocols in the literature (there is not yet one agreed-upon standard). "Radiation risk models, derived using data from Japanese atomic bomb survivors and medically exposed cohorts, were used to estimate the excess lifetime risk of radiation-induced cancer," the authors write.

Because of differences in scanner models and techniques, radiation dose from a single scan varied more than 10-fold, the authors note. Organs or tissues estimated to receive measurable radiation doses included the breast, lung, thyroid, esophagus, bone surface and adrenal glands. "The wide dose variation also resulted in wide variation in estimated radiation-induced cancer risk," they continue. "Assuming screening every five years from the age of 45 to 75 years for men and 55 to 75 years for women, the estimated excess lifetime cancer risk using the median dose of 2.3 millisieverts was 42 cases per 100,000 men (range, 14 to 200 cases) and 62 cases per 100,000 women (range, 21 to 300 cases)."

There are currently no estimates of the benefits of CT screening for coronary artery calcification, but when they become available, they could be compared with these estimates of radiation-induced cancer risk to design appropriate detection and prevention strategies. "Many technical factors influence radiation dose from coronary artery calcification measurement with multidetector CT," the authors write. "Careful optimization of these factors may reduce radiation exposure without detriment to the clinical purpose of the screening examination. Further efforts by professional societies are necessary to standardize protocols in order to decrease unnecessary radiation exposure and to minimize cancer risk."

(Arch Intern Med. 2009;169[13]:1188-1194. Available pre-embargo to the media at

Editor's Note: Co-author Dr. Einstein is supported in part by a National Institutes of Health K12 Institutional Career Development Award. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Editorial: Results Shed Light on Risks and Benefits

"The critical appraisal of any medical test or strategy requires careful assessment of its potential risks, benefits and costs," write Raymond J. Gibbons, M.D., and Thomas C. Gerber, M.D., Ph.D., of Mayo Clinic, Rochester, Minn., in an accompanying editorial.

"Accurate definition of the risks, benefits and costs of the use of coronary artery calcium scanning with computed tomography in asymptomatic individuals remains an elusive goal," they write. "In this issue of the Archives, Kim et al contribute to our knowledge about potential risks by reporting estimated radiation doses and excess lifetime risks of radiation-induced cancer from coronary artery calcium scanning for a variety of CT scanners and scanning protocols that have been described in the literature."

"For patients in whom coronary artery calcium scoring is considered, health care providers should ideally discuss the potential risks and benefits of the procedure," they conclude. "This discussion should include the small radiation (and potential cancer) risk described by Kim et al."

(Arch Intern Med. 2009;169[13]:1185-1187. Available pre-embargo to the media at

Editor's Note: Dr. Gerber was supported in part by a grant from the National Institutes of Health. Please see the article for additional information, including author contributions and affiliations, financial disclosures, funding and support, etc.
To contact editorial author Raymond J. Gibbons, M.D., call Traci Klein at 507-284-5005 or e-mail For more information, contact JAMA/Archives Media Relations at 312/464-JAMA (5262) or e-mail

The JAMA Network Journals

Related Radiation Articles from Brightsurf:

Sheer protection from electromagnetic radiation
A printable ink that is both conductive and transparent can also block radio waves.

What membrane can do in dealing with radiation
USTC recently found that polymethylmethacrylate (PMMA) and polyvinyl chloride (PVC) can release acidic substance under γ radiation, whose amount is proportional to the radiation intensity.

First measurements of radiation levels on the moon
In the current issue (25 September) of the prestigious journal Science Advances, Chinese and German scientists report for the first time on time-resolved measurements of the radiation on the moon.

New biomaterial could shield against harmful radiation
Northwestern University researchers have synthesized a new form of melanin enriched with selenium.

A new way to monitor cancer radiation therapy doses
More than half of all cancer patients undergo radiation therapy and the dose is critical.

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
Oncotarget Volume 11, Issue 4: In this study, locally advanced head and neck cancer patients undergoing definitive chemoradiation were randomly allocated to weekly cisplatin - radiation {CRT arm} or nimotuzumab -weekly cisplatin -radiation {NCRT arm}.

Breaking up amino acids with radiation
A new experimental and theoretical study published in EPJ D has shown how the ions formed when electrons collide with one amino acid, glutamine, differ according to the energy of the colliding electrons.

Radiation breaks connections in the brain
One of the potentially life-altering side effects that patients experience after cranial radiotherapy for brain cancer is cognitive impairment.

Fragmenting ions and radiation sensitizers
The anti-cancer drug 5-fluorouracil (5FU) acts as a radiosensitizer: it is rapidly taken up into the DNA of cancer cells, making the cells more sensitive to radiotherapy.

'Seeing the light' behind radiation therapy
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime.

Read More: Radiation News and Radiation Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to